(Total Views: 116)
Posted On: 12/07/2022 10:20:48 AM
Post# of 35809

$AXSM News Article - Axsome Therapeutics Presents New Data from the EVOLVE Open-Label Trial Demonstrating Effects of AUVELITY on Cognitive and Physical Functioning in Patients with Major Depressive Disorder at the American College of Neuropsychopharmacology (ACNP) 2022 https://marketwirenews.com/news-releases/axso...82436.html


My Twitter: WhyteStocks